Jubilant Pharmova has announced an investment of CAD 30,000 (approximately INR 0.20 crores) in Jubilant Pharmaceuticals Inc., Canada, effective December 30, 2025. This investment establishes Jubilant Pharmaceuticals Inc. as a step-down wholly-owned subsidiary, marking an expansion of the company’s presence in the Canadian market. The move aims to establish a branded generics business in Canada and strengthen Jubilant’s overall market position.
Canadian Expansion
Jubilant Pharmova has made an initial investment in Jubilant Pharmaceuticals Inc., Canada. As of December 30, 2025, the company invested CAD 30,000 (approximately INR 0.20 crores) to subscribe to 30,000 common shares.
Subsidiary Status
Following the investment, Jubilant Pharmaceuticals Inc. has become a step-down wholly-owned subsidiary of Jubilant Pharmova. Jubilant Pharmaceuticals Inc. was incorporated on June 17, 2025, under the Canada Business Corporations Act.
Strategic Rationale
The investment aims to establish a branded generics business in Canada, strengthen Jubilant’s presence in the Canadian market, and potentially drive revenue growth. Jubilant Pharmaceutical Inc’s turnover is currently Nil, and it is yet to commence its business operations.
Source: BSE
